Comparative Efficacy Study of Titratable Versus Active Mandibular Advancement Splint in Sleep Apnea
NCT ID: NCT02112435
Last Updated: 2024-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2014-08-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraoral Appliance in the Treatment of Obstructive Sleep Apnea Syndrome in Obese
NCT03517150
Evaluation of a Mandibular Advancement Device in the Treatment of Obstructive Sleep Apnea Syndrome
NCT00213434
Impact of Interface With/Without Oral Appliance of Sleep Apnea Treatment
NCT01889472
Adherence and Preference of Continuous Positive Airway Pressure Versus Mandibular Advancement Splints in Obstructive Sleep Apnea Patients: A Randomized Trial
NCT02242617
Differences in Predicted Therapeutic Outcome of Oral Appliance Determined by RCMP in Quebec Versus Shenyang Patients With OSA.
NCT03231254
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Narval ORM ® or SomnoDent ®
Mandibular advancement splint (Narval ORM ® or SomnoDent ®)
Narval ORM ® or SomnoDent ®
Mandibular advancement splint
Somnyx ®
Active mandibular advancement splint (Somnyx ®)
Somnyx ®
Active mandibular advancement splint
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Somnyx ®
Active mandibular advancement splint
Narval ORM ® or SomnoDent ®
Mandibular advancement splint
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* severe OSA confirmed by polysomnography (PSG) is: 30\> AHI\> 15 with severe daytime sleepiness - Epworth ≥ 10 or AHI\> 30
* patient in failure or refusal of CPAP treatment
* agree to participate and sign the consent form research
* speak and understand French without external assistance
* be in good health (no neurological or psychiatric syndrome).
* have a valid Social Security card (in France and Portugal only)
Exclusion Criteria
* dental restorations in progress or planned in the next 6 months
* psychiatric and neuromuscular disorders
* untreated cardiovascular diseases and history of stroke or myocardial infarction
* severe or morbid obesity (body mass index\> 35)
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Hospitalier Pitie-Salpetriere
OTHER
University Hospital, Montpellier
OTHER
Université de Montréal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nelly Huynh
Assistant research professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nelly Huynh, PhD
Role: PRINCIPAL_INVESTIGATOR
Université de Montréal
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université de Montréal
Montreal, Quebec, Canada
Université Montpellier
Montpellier, , France
Groupe Hospitalier Pitie-Salpetriere
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NH-14SRP-Somnyx
Identifier Type: OTHER
Identifier Source: secondary_id
14-011-CERES-D
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.